Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Translational Neurodegeneration
Published in: Translational Neurodegeneration 1/2018

Open Access 01-12-2018 | Review

Chinese expert consensus on programming deep brain stimulation for patients with Parkinson’s disease

Authors: Shengdi Chen, Guodong Gao, Tao Feng, Jianguo Zhang, The Chinese Medical Association neurosurgery branch of functional neurosurgery group, The Chinese Medical Association neurology branch of Parkinson’s disease, Movement disorders group, The Chinese Physician Association neurosurgeon branch of functional neurosurgery expert committee, The Chinese Physician Association neurologist branch of Parkinson’s disease and Movement disorders professional committee, Chinese expert committee on Deep Brain Stimulation for Parkinson’s Disease

Published in: Translational Neurodegeneration | Issue 1/2018

Login to get access

Abstract

Background

Deep Brain Stimulation (DBS) therapy for the treatment of Parkinson’s Disease (PD) is now a well-established option for some patients. Postoperative standardized programming processes can improve the level of postoperative management and programming, relieve symptoms and improve quality of life.

Main body

In order to improve the quality of the programming, the experts on DBS and PD in neurology and neurosurgery in China reviewed the relevant literatures and combined their own experiences and developed this expert consensus on the programming of deep brain stimulation in patients with PD in China.

Conclusion

This Chinese expert consensus on postoperative programming can standardize and improve postoperative management and programming of DBS for PD.
Literature
1.
Chinese expert committee on Deep Brain Stimulation for Parkinson's Disease. Chinese expert consensus on deep brain stimulation for patients with Parkinson's disease. Chin J Neurosurg. 2012;28(8):855–7.
2.
Chinese expert committee on Deep Brain Stimulation for Parkinson's Disease. Chinese expert consensus on deep brain stimulation for patients with Parkinson's disease. Chin J Neurol. 2012;45(7):541–3.
3.
Postuma RB, et al. MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord. 2015;30(12):1591–601.CrossRefPubMed
4.
The Chinese Medical Association neurology branch of Parkinson's disease and Movement disorders group. The Chinese physician association neurologist branch of Parkinson's disease and movement disorders professional committee. Chinese diagnostic criteria for patients with Parkinson's disease. Chin J Neurol. 2016;49(4):268–71.
5.
The Chinese Medical Association neurology branch of Parkinson's disease and Movement disorders group. Chinese treatment guidelines for patients with Parkinson's disease. Chin J Neurol. 2014;6:428–33.
6.
Picillo M, et al. Programming deep brain stimulation for Parkinson's disease: the Toronto western hospital algorithms. Brain Stimul. 2016;9(3):425–37.CrossRefPubMed
7.
Beaulieu-Boire I, Fasano A. Current or voltage? Another Shakespearean dilemma. Eur J Neurol. 2015;22(6):887–8.CrossRefPubMed
8.
Bronstein JM, et al. Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues. Arch Neurol. 2011;68(2):165.CrossRefPubMed
9.
Deuschl G, et al. Deep brain stimulation: postoperative issues. Mov Disord. 2006;21(Suppl 14):S219–37.CrossRefPubMed
10.
Volkmann J, Moro E, Pahwa R. Basic algorithms for the programming of deep brain stimulation in Parkinson's disease. Mov Disord. 2006;21(Suppl 14):S284–9.CrossRefPubMed
11.
Li P, et al. Pilot study on a fast postoperative programming approach to subthalamic nucleus stimulation in Parkinson's disease. Neurol India. 2011;59(5):669–73.CrossRefPubMed
12.
Moro E, et al. The impact on Parkinson's disease of electrical parameter settings in STN stimulation. Neurology. 2002;59(5):706–13.CrossRefPubMed
13.
Jia F, et al. Variable frequency stimulation of subthalamic nucleus for freezing of gait in Parkinson's disease. Parkinsonism Relat Disord. 2015;21(12):1471–2.CrossRefPubMed
14.
15.
Zibetti M, et al. Low-frequency subthalamic stimulation in Parkinson's disease: long-term outcome and predictors. Brain Stimul. 2016;9(5):774–9.CrossRefPubMed
16.
de Noriega FR, et al. Constant current versus constant voltage subthalamic nucleus deep brain stimulation in Parkinson's disease. Stereotact Funct Neurosurg. 2015;93(2):114–21.CrossRef
17.
Okun MS, et al. Subthalamic deep brain stimulation with a constant-current device in Parkinson's disease: an open-label randomised controlled trial. Lancet Neurol. 2012;11(2):140–9.CrossRefPubMed
18.
Preda F, et al. Switching from constant voltage to constant current in deep brain stimulation: a multicenter experience of mixed implants for movement disorders. Eur J Neurol. 2016;23(1):190–5.CrossRefPubMed
19.
Bronstein JM, et al. The rationale driving the evolution of deep brain stimulation to constant-current devices. Neuromodulation. 2015;18(2):85–8. discussion 88-9.CrossRefPubMed
20.
Ramirez-Zamora A, et al. Interleaved programming of subthalamic deep brain stimulation to avoid adverse effects and preserve motor benefit in Parkinson's disease. J Neurol. 2015;262(3):578–84.CrossRefPubMed
21.
Wojtecki L, Vesper J, Schnitzler A. Interleaving programming of subthalamic deep brain stimulation to reduce side effects with good motor outcome in a patient with Parkinson's disease. Parkinsonism Relat Disord. 2011;17(4):293–4.CrossRefPubMed
22.
Brosius SN, et al. Reversible improvement in severe freezing of gait from Parkinson's disease with unilateral interleaved subthalamic brain stimulation. Parkinsonism Relat Disord. 2015;21(12):1469–70.CrossRefPubMed
23.
24.
Ramdhani RA, et al. Early use of 60 Hz frequency subthalamic stimulation in Parkinson's disease: a case series and review. Neuromodulation. 2015;18(8):664–9.CrossRefPubMed
25.
Vallabhajosula S, et al. Low-frequency versus high-frequency subthalamic nucleus deep brain stimulation on postural control and gait in Parkinson's disease: a quantitative study. Brain Stimul. 2015;8(1):64–75.CrossRefPubMed
26.
di BL. Fasano a. Low-frequency deep brain stimulation for Parkinson's disease: great expectation or false hope? Mov Disord. 2016;31(7):962–7.CrossRef
27.
Aquino CC, Fox SH. Clinical spectrum of levodopa-induced complications. Mov Disord. 2015;30(1):80–9.CrossRefPubMed
28.
29.
Odin P, et al. Collective physician perspectives on non-oral medication approaches for the management of clinically relevant unresolved issues in Parkinson's disease: consensus from an international survey and discussion program. Parkinsonism Relat Disord. 2015;21(10):1133–44.CrossRefPubMed
30.
31.
Fasano A, et al. Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants. Brain. 2010;133(9):2664–76.CrossRefPubMed
32.
Tommasi G, et al. Freezing and hypokinesia of gait induced by stimulation of the subthalamic region. J Neurol Sci. 2007;258(1–2):99–103.CrossRefPubMed
33.
Fasano A, et al. Modulation of gait coordination by subthalamic stimulation improves freezing of gait. Mov Disord. 2011;26(5):844–51.CrossRefPubMed
34.
Belasen A, et al. Effect of low-frequency deep brain stimulation on sensory thresholds in Parkinson's disease. J Neurosurg, 2017;126(2):397–403.
35.
Cury RG, et al. Effects of deep brain stimulation on pain and other nonmotor symptoms in Parkinson disease. Neurology. 2014;83(16):1403–9.CrossRefPubMed
36.
Jung YJ, et al. An 8-year follow-up on the effect of subthalamic nucleus deep brain stimulation on pain in Parkinson disease. JAMA Neurol. 2015;72(5):504–10.CrossRefPubMed
37.
Wu B, et al. Influence of deep brain stimulation of the subthalamic nucleus on cognitive function in patients with Parkinson's disease. Neurosci Bull. 2014;30(1):153–61.CrossRefPubMed
38.
Witt K, et al. Relation of lead trajectory and electrode position to neuropsychological outcomes of subthalamic neurostimulation in Parkinson's disease: results from a randomized trial. Brain. 2013;136(Pt 7):2109–19.CrossRefPubMed
39.
Wang JW, et al. Cognitive and psychiatric effects of STN versus GPi deep brain stimulation in Parkinson's disease: a meta-analysis of randomized controlled trials. PLoS One. 2016;11(6):e0156721.CrossRefPubMedPubMedCentral
40.
Deuschl G, Paschen S, Witt K. Clinical outcome of deep brain stimulation for Parkinson's disease. Handb Clin Neurol. 2013;116:107–28.CrossRefPubMed
41.
Wojtecki L, et al. Frequency-dependent reciprocal modulation of verbal fluency and motor functions in subthalamic deep brain stimulation. Arch Neurol. 2006;63(9):1273–6.CrossRefPubMed
42.
Zhao XM, Liu Y, Meng FG. Progress on anatomy of subthalamic nucleus. Chin. J Neurosurg. 2016;32(3):304–6.
43.
Connolly BS, Lang AE. Pharmacological treatment of Parkinson disease: a review. JAMA. 2014;311(16):1670–83.CrossRefPubMed
44.
Wang HF, et al. Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis. J Neurol Neurosurg Psychiatry. 2015;86(2):135–43.CrossRefPubMed
45.
Kim HJ, et al. Long-term cognitive outcome of bilateral subthalamic deep brain stimulation in Parkinson's disease. J Neurol. 2014;261(6):1090–6.CrossRefPubMed
46.
Combs HL, et al. Cognition and depression following deep brain stimulation of the subthalamic nucleus and Globus pallidus pars internus in Parkinson's disease: a meta-analysis. Neuropsychol Rev. 2015;25(4):439–54.CrossRefPubMed
47.
Volkmann J, Daniels C, Witt K. Neuropsychiatric effects of subthalamic neurostimulation in Parkinson disease. Nat Rev Neurol. 2010;6(9):487–98.CrossRefPubMed
48.
Ferreira JJ, et al. Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease. Eur J Neurol. 2013;20(1):5–15.CrossRefPubMed
49.
Voon V, et al. Deep brain stimulation: neuropsychological and neuropsychiatric issues. Mov Disord. 2006;21(Suppl 14):S305–27.CrossRefPubMed
50.
Mosley PE, Marsh R. The psychiatric and neuropsychiatric symptoms after subthalamic stimulation for Parkinson's disease. J Neuropsychiatry Clin Neurosci. 2015;27(1):19–26.CrossRefPubMed
51.
Thobois S, et al. Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation. Brain. 2010;133(Pt 4):1111–27.CrossRefPubMed
52.
Fasano A, et al. Medical Management of Parkinson's disease after initiation of deep brain stimulation. Can J Neurol Sci. 2016;43(5):626–34.CrossRefPubMed
53.
Cooney JW, Stacy M. Neuropsychiatric issues in Parkinson's disease. Curr Neurol Neurosci Rep. 2016;16(5):49.CrossRefPubMed
54.
Deuschl G, et al. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med. 2006;355(9):896–908.CrossRefPubMed
55.
Williams A, et al. Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial. Lancet Neurol. 2010;9(6):581–91.CrossRefPubMedPubMedCentral
Metadata
Title
Chinese expert consensus on programming deep brain stimulation for patients with Parkinson’s disease
Authors
Shengdi Chen
Guodong Gao
Tao Feng
Jianguo Zhang
The Chinese Medical Association neurosurgery branch of functional neurosurgery group
The Chinese Medical Association neurology branch of Parkinson’s disease
Movement disorders group
The Chinese Physician Association neurosurgeon branch of functional neurosurgery expert committee
The Chinese Physician Association neurologist branch of Parkinson’s disease and Movement disorders professional committee
Chinese expert committee on Deep Brain Stimulation for Parkinson’s Disease
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Translational Neurodegeneration / Issue 1/2018
Electronic ISSN: 2047-9158
DOI
https://doi.org/10.1186/s40035-018-0116-x

Other articles of this Issue 1/2018

Translational Neurodegeneration 1/2018 Go to the issue

Review

Impact of the biological definition of Alzheimer’s disease using amyloid, tau and neurodegeneration (ATN): what about the role of vascular changes, inflammation, Lewy body pathology?

Research

Alpha-synuclein overexpression in the olfactory bulb initiates prodromal symptoms and pathology of Parkinson’s disease

Research

Objective assessment of bradykinesia in Parkinson’s disease using evolutionary algorithms: clinical validation

Research

Divergent topological networks in Alzheimer’s disease: a diffusion kurtosis imaging analysis

Review

Treating refractory depression in Parkinson’s disease: a meta-analysis of transcranial magnetic stimulation

Research

Intranasal rapamycin ameliorates Alzheimer-like cognitive decline in a mouse model of Down syndrome